Skip to content
This GLP
Updated September 2026Monthly billing, four-week fill

Remedy Meds review

Billing runs monthly and the fill runs four weeks, which is not the same year.

The verdict

Remedy Meds publishes $299 for compounded semaglutide and $399 for tirzepatide, read August 2026, billed monthly against a four-week supply. Thirteen fills a year make the real figures $324 and $432.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
$324/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Remedy Meds sells both molecules by injection with a microdose entry tier and prepaid plans running from three to twelve months.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages describe plans and tiers. The clinician is not described anywhere a reader can reach.

    The ladder here is unusually deep and the cycle underneath it is easy to miss. Prepaying three to twelve months moves the figure a long way, and none of those movements changes the four-week fill.

  2. What happens when the dose goes up?

    Nothing states what the standard figures do at a higher dose. A microdose tier from $189 is offered, which is a different product rather than a lower rung of the same one.

  3. What the price includes

    Thirteen fills at $299 is $3,887 a year, or $324 a calendar month, and tirzepatide at $399 comes to $432. Prepaying brings semaglutide to between $249 and $149 a month depending on term, and tirzepatide to between $349 and $299. The microdose tier starts at $189 on both lines.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: Prepaid rungs published from three to twelve months
  • Strength: A microdose entry tier is priced
  • Strength: The four-week supply is recorded
  • Limitation: Thirteen fills a year, not twelve
  • Limitation: The lowest rungs need long prepayment
  • Limitation: The microdose tier is a different product
  • Limitation: No state coverage list is recorded

What the evidence says about this kind of treatment

The assessment above is about Remedy Meds. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader comparing prepaid terms who counts the fills rather than the months.
Wrong for
A reader taking $299 as a calendar-month figure.

How Remedy Meds compares

SellerWho it suitsGo
Prime HealthReaders who count charges rather than monthsSee Prime Health
RestorLife MedReaders who want monitoring included rather than billed separatelySee RestorLife Med
Revive MedsReaders who will commit a year and want to see every rung firstSee Revive Meds
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: MadeMedMagnolia Regenerative MedicineMANÜ TelehealthMaximusMaxLifeMDExam

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

Is $299 a calendar month?
No. Billing is monthly against a four-week supply, which is thirteen fills a year, or $324 a month.
How low do the prepaid plans go?
$149 a month for semaglutide and $299 for tirzepatide at the longest terms.
What is the microdose tier?
A separate lower-dose product from $189 a month, not a lower rung of the standard plan.
Is Remedy Meds expensive compared with other GLP-1 telehealth sellers?
Remedy Meds publishes a starting figure of $324/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Remedy Meds above the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Remedy Meds’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.